tiprankstipranks
Trending News
More News >
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ:TARS
US Market

Compare Tarsus Pharmaceuticals (TARS) vs. Competitors

Compare
256 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Tarsus Pharmaceuticals
$78.21
$3.26B
-37.51
48.43%
6 Buy
1 Hold
0 Sell
Strong Buy
Denali Therapeutics
$17.95
$2.67B
-6.17
-10.63%
13 Buy
0 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$26.78
$3.46B
-75.54
116.36%
7 Buy
1 Hold
0 Sell
Strong Buy
Beam Therapeutics
$33.69
$2.80B
-7.60
6.10%
10 Buy
3 Hold
0 Sell
Strong Buy
Disc Medicine
$79.02
$2.95B
-14.75
33.83%
13 Buy
0 Hold
0 Sell
Strong Buy
Recursion Pharmaceuticals
$4.81
$2.43B
-2.66
-30.09%
2 Buy
4 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TARS
Tarsus Pharmaceuticals
75.53
31.20
70.38%
DNLI
Denali Therapeutics
17.95
-0.79
-4.22%
ARQT
Arcutis Biotherapeutics
26.78
13.50
101.66%
BEAM
Beam Therapeutics
33.69
10.39
44.59%
IRON
Disc Medicine
79.02
21.19
36.64%
RXRX
Recursion Pharmaceuticals
4.81
-1.51
-23.89%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts